LC determination of rosiglitazone in bulk and pharmaceutical formulation
- 14 May 2002
- journal article
- Published by Elsevier BV in Journal of Pharmaceutical and Biomedical Analysis
- Vol. 29 (5), 873-880
- https://doi.org/10.1016/s0731-7085(02)00209-1
Abstract
No abstract availableKeywords
This publication has 4 references indexed in Scilit:
- Automated high-performance liquid chromatography method for the determination of rosiglitazone in human plasmaJournal of Chromatography B: Biomedical Sciences and Applications, 2001
- High-performance liquid chromatographic determination of irinotecan (CPT-11) and its active metabolite (SN-38) in human plasmaJournal of Chromatography B: Biomedical Sciences and Applications, 1995
- Quantitative Determination of Oxaprozin and Several of Its Related Compounds by High-Performance Reversed-Phase Liquid ChromatographyJournal of Liquid Chromatography, 1995
- New concepts in the pathogenesis and treatment of noninsulin-dependent diabetes mellitusAmerican Journal Of Medicine, 1983